Home
/
Guardant Health, Inc.
/
Financials
/
Quarterly
Guardant Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Guardant Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$265.20M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$232.09M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$203.47M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$191.48M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$177.24M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$168.49M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$143.03M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$137.15M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$128.71M
May 9, 2024
Q3
2023
Sep 30, 2022
$117.40M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$109.14M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$96.10M
May 9, 2023
Q3
2022
Sep 30, 2021
$94.78M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$92.10M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$78.67M
May 5, 2022
Q3
2021
Sep 30, 2020
$74.57M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$66.34M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$67.51M
May 6, 2021
Q3
2020
Sep 30, 2019
$60.85M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$53.98M
Aug 6, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$265.20M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$232.09M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$203.47M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$191.48M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$177.24M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$168.49M
Apr 30, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($92.73M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($99.90M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($95.16M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($107.75M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
($102.63M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($114.99M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($86.10M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($72.77M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($133.53M)
May 9, 2024
Q3
2023
Sep 30, 2022
($161.99M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($229.43M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($123.23M)
May 9, 2023
Q4
2018
Dec 31, 2018
($85.06M)
Mar 19, 2019
Q3
2018
Sep 30, 2018
($24.46M)
Nov 19, 2018
Q4
2018
Dec 31, 2017
($83.22M)
Mar 19, 2019
Q3
2018
Sep 30, 2017
($28.59M)
Nov 19, 2018
Q4
2018
Dec 31, 2016
($46.14M)
Mar 19, 2019
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($98.99M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($106.41M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($111.04M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($117.33M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
($100.62M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($99.68M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($113.54M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($119.62M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($134.06M)
May 9, 2024
Q3
2023
Sep 30, 2022
($144.60M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($130.32M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($123.34M)
May 9, 2023
Q3
2022
Sep 30, 2021
($107.29M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($97.64M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($107.86M)
May 5, 2022
Q3
2021
Sep 30, 2020
($74.25M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($54.62M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($34.91M)
May 6, 2021
Q3
2020
Sep 30, 2019
($17.48M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($15.27M)
Aug 6, 2020